{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:12:05Z","timestamp":1790435525136,"version":"4.1.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol"],"published-print":{"date-parts":[[2012,4,1]]},"DOI":"10.1001\/archdermatol.2011.2768","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T20:17:52Z","timestamp":1334607472000},"page":"463","source":"Crossref","is-referenced-by-count":184,"title":["Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy"],"prefix":"10.1001","volume":"148","author":[{"given":"Gregorio","family":"Carretero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["Archives of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/1150963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T03:18:34Z","timestamp":1481944714000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/archdermatol.2011.2768"}},"subtitle":["Patients Ineligible vs Eligible for Randomized Controlled Trials"],"short-title":[],"issued":{"date-parts":[[2012,4,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/archdermatol.2011.2768","relation":{},"ISSN":["0003-987X"],"issn-type":[{"value":"0003-987X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4,1]]}}}